BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 29143081)

  • 1. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles.
    Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I
    Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization and epitope mapping of monoclonal antibodies raised against rat hepatitis E virus capsid protein: An evaluation of their neutralizing activity in a cell culture system.
    Kobayashi T; Takahashi M; Tanggis ; Mulyanto ; Jirintai S; Nagashima S; Nishizawa T; Okamoto H
    J Virol Methods; 2016 Jul; 233():78-88. PubMed ID: 26992654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs.
    Wang X; Zhao Q; Dang L; Sun Y; Gao J; Liu B; Syed SF; Tao H; Zhang G; Luo J; Zhou EM
    J Virol; 2015 May; 89(10):5491-501. PubMed ID: 25741007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus.
    Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of antigenic epitopes of the ORF2 protein from hepatitis E virus genotype 4.
    Zhang H; Dai X; Shan X; Meng J
    Virus Res; 2009 Jun; 142(1-2):140-3. PubMed ID: 19428747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification by phage display and characterization of two neutralizing chimpanzee monoclonal antibodies to the hepatitis E virus capsid protein.
    Schofield DJ; Glamann J; Emerson SU; Purcell RH
    J Virol; 2000 Jun; 74(12):5548-55. PubMed ID: 10823861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies.
    Riddell MA; Li F; Anderson DA
    J Virol; 2000 Sep; 74(17):8011-7. PubMed ID: 10933710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of a special neutralizing epitope of HEV E2s.
    You M; Xin L; Yang Y; Zhang X; Chen Y; Yu H; Li S; Zhang J; An Z; Luo W; Xia N
    Protein Cell; 2014 Dec; 5(12):950-3. PubMed ID: 25416205
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterization of capsid protein (p495) of hepatitis E virus expressed in Escherichia coli and assembling into particles in vitro.
    Zheng M; Jiang J; Zhang X; Wang N; Wang K; Li Q; Li T; Lin Q; Wang Y; Yu H; Gu Y; Zhang J; Li S; Xia N
    Vaccine; 2018 Apr; 36(16):2104-2111. PubMed ID: 29544686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Comprehensive Study of Neutralizing Antigenic Sites on the Hepatitis E Virus (HEV) Capsid by Constructing, Clustering, and Characterizing a Tool Box.
    Zhao M; Li XJ; Tang ZM; Yang F; Wang SL; Cai W; Zhang K; Xia NS; Zheng ZZ
    J Biol Chem; 2015 Aug; 290(32):19910-22. PubMed ID: 26085097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic composition and immunoreactivity differences between HEV recombinant capsid proteins generated from different genotypes.
    Behloul N; Wen J; Dai X; Dong C; Meng J
    Infect Genet Evol; 2015 Aug; 34():211-20. PubMed ID: 26122075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression,Purification,Structure Determination and Immunogenicity Assay of Hepatitis E Virus Capsid Protein p495 Derived from Baculovirus-based Insect Cell].
    Lin Q; Jiang J; Li T; Zhang Y; Zhang Z; Zheng M; Wang K; Zheng Q; Yu H; Gu Y; Xia N; Li S
    Bing Du Xue Bao; 2016 May; 32(3):342-8. PubMed ID: 29963821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Production of monoclonal antibodies against hepatitis E virus capsid protein and evaluation of their neutralizing activity in a cell culture system.
    Takahashi M; Hoshino Y; Tanaka T; Takahashi H; Nishizawa T; Okamoto H
    Arch Virol; 2008; 153(4):657-66. PubMed ID: 18266052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus.
    Mazalovska M; Kouokam JC
    Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of chimeric virus-like particles harbouring a segment of hantavirus Gc glycoprotein to generate a broadly-reactive hantavirus-specific monoclonal antibody.
    Zvirbliene A; Kucinskaite-Kodze I; Razanskiene A; Petraityte-Burneikiene R; Klempa B; Ulrich RG; Gedvilaite A
    Viruses; 2014 Feb; 6(2):640-60. PubMed ID: 24513568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial configuration of hepatitis E virus antigenic domain.
    Xing L; Wang JC; Li TC; Yasutomi Y; Lara J; Khudyakov Y; Schofield D; Emerson SU; Purcell RH; Takeda N; Miyamura T; Cheng RH
    J Virol; 2011 Jan; 85(2):1117-24. PubMed ID: 21068233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characterization of antigenic epitopes of ORF2 encoded proteins of hepatitis E virus genotype 4 identified in China].
    Zhang HM; Dai X; Meng JH; Zhao Y; Shan XN
    Yi Chuan; 2007 May; 29(5):637-42. PubMed ID: 17548336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Leu477 and Leu613 of ORF2-encoded protein are critical in forming neutralization antigenic epitope of hepatitis E virus genotype 4.
    Zhang H; Dai X; Shan X; Meng J
    Cell Mol Immunol; 2008 Dec; 5(6):447-56. PubMed ID: 19118511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation.
    Li Y; Huang X; Zhang Z; Li S; Zhang J; Xia N; Zhao Q
    Viruses; 2020 Jan; 12(1):. PubMed ID: 31963175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice.
    Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S
    Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.